Kristina M. Brooks

1.5k total citations
44 papers, 675 citations indexed

About

Kristina M. Brooks is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kristina M. Brooks has authored 44 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 10 papers in Virology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kristina M. Brooks's work include HIV/AIDS drug development and treatment (23 papers), HIV/AIDS Research and Interventions (18 papers) and HIV Research and Treatment (10 papers). Kristina M. Brooks is often cited by papers focused on HIV/AIDS drug development and treatment (23 papers), HIV/AIDS Research and Interventions (18 papers) and HIV Research and Treatment (10 papers). Kristina M. Brooks collaborates with scholars based in United States, Singapore and Ethiopia. Kristina M. Brooks's co-authors include Parag Kumar, Peter L. Anderson, Jomy George, José Castillo‐Mancilla, Robert Evers, Ashkan A. Malayeri, Jennifer J. Kiser, Daniel S. Reich, L. Henry Bryant and David A. Bluemke and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Experimental Neurology.

In The Last Decade

Kristina M. Brooks

38 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina M. Brooks United States 15 308 183 98 95 87 44 675
Jasper van der Lugt Netherlands 17 277 0.9× 96 0.5× 138 1.4× 28 0.3× 163 1.9× 59 808
Gavin Wong United Kingdom 10 65 0.2× 486 2.7× 44 0.4× 73 0.8× 102 1.2× 14 997
Jinsil Kim South Korea 13 186 0.6× 110 0.6× 55 0.6× 51 0.5× 226 2.6× 16 789
Jack Rodman United States 12 215 0.7× 112 0.6× 109 1.1× 29 0.3× 84 1.0× 53 518
Stacey A. Rizza United States 14 231 0.8× 181 1.0× 245 2.5× 140 1.5× 94 1.1× 42 558
Jennifer La United States 15 229 0.7× 90 0.5× 52 0.5× 58 0.6× 189 2.2× 66 733
Qiwen Fang China 11 187 0.6× 357 2.0× 42 0.4× 196 2.1× 117 1.3× 34 1.2k
Ranjababu Kulasegaram United Kingdom 19 526 1.7× 392 2.1× 349 3.6× 13 0.1× 49 0.6× 66 1.0k
Jori E. May United States 10 78 0.3× 46 0.3× 102 1.0× 65 0.7× 66 0.8× 43 429
Heather Vezina United States 15 225 0.7× 231 1.3× 57 0.6× 190 2.0× 102 1.2× 25 894

Countries citing papers authored by Kristina M. Brooks

Since Specialization
Citations

This map shows the geographic impact of Kristina M. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina M. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina M. Brooks more than expected).

Fields of papers citing papers by Kristina M. Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina M. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina M. Brooks. The network helps show where Kristina M. Brooks may publish in the future.

Co-authorship network of co-authors of Kristina M. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina M. Brooks. A scholar is included among the top collaborators of Kristina M. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina M. Brooks. Kristina M. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Branchford, Brian R., Travis Nemkov, B. D. Johnson, et al.. (2025). Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIV. Journal of Antimicrobial Chemotherapy. 80(5). 1224–1232.
2.
3.
Stranix‐Chibanda, Lynda, Kristina M. Brooks, & Ahizechukwu C. Eke. (2024). Care of Pregnant Women Living with Human Immunodeficiency Virus. Clinics in Perinatology. 51(4). 749–767.
4.
Chappell, Catherine A., Jennifer J. Kiser, Kristina M. Brooks, et al.. (2024). Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus. Clinical Infectious Diseases. 80(4). 744–751. 2 indexed citations
5.
Powis, Kathleen M., Alice Stek, Kristina M. Brooks, et al.. (2024). Pharmacokinetics and Safety of Bictegravir in Pregnant and Postpartum Persons With HIV and Their Infants. JAIDS Journal of Acquired Immune Deficiency Syndromes. 98(3). 300–307.
6.
Chandasana, Hardik, Rashmi Mehta, Mark Bush, et al.. (2024). Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1. Infectious Diseases and Therapy. 13(8). 1877–1891. 1 indexed citations
7.
8.
Brooks, Kristina M., Kimberly K. Scarsi, & Mark Mirochnick. (2023). Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy. Obstetrics and Gynecology Clinics of North America. 50(1). 205–218. 1 indexed citations
9.
Brooks, Kristina M., Rachel K. Scott, Brookie M. Best, Edmund V. Capparelli, & Jeremiah D. Momper. (2023). Translating Clinical Pharmacology Data in Pregnancy to Evidence‐Based Guideline Recommendations: Perspectives From the HIV Field. The Journal of Clinical Pharmacology. 63(S1). S188–S196. 2 indexed citations
10.
Brooks, Kristina M., Jennifer Brothers, Kathleen Mulligan, et al.. (2022). Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate. AIDS Research and Human Retroviruses. 38(12). 939–943. 9 indexed citations
11.
Brooks, Kristina M., Jennifer Brothers, Kathleen Mulligan, et al.. (2022). Pharmacokinetics of Emtricitabine/Tenofovir Disoproxil Fumarate Among Transgender Adolescents and Young Adults Without HIV Receiving Gender Affirming Hormones. AIDS Research and Human Retroviruses. 38(11). 840–846. 7 indexed citations
12.
Morrow, Mary, Samantha MaWhinney, Kristina M. Brooks, et al.. (2022). Improving the accuracy of adherence data collected using medication monitoring technology in clinical research. Contemporary Clinical Trials. 125. 107051–107051. 1 indexed citations
13.
Brooks, Kristina M., et al.. (2022). The use of technology-based adherence monitoring in the treatment of hepatitis C virus. Therapeutic Advances in Infectious Disease. 9. 2008330480–2008330480. 8 indexed citations
14.
Ibrahim, Mustafa E., José Castillo‐Mancilla, Kristina M. Brooks, et al.. (2020). Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis. AIDS Research and Human Retroviruses. 37(6). 421–428. 10 indexed citations
15.
Brooks, Kristina M.. (2019). A Way Forward — Navigating the Integrative Medical Paradigm. 26(2). 17–19.
16.
Ibrahim, Mustafa E., Kristina M. Brooks, José Castillo‐Mancilla, et al.. (2018). Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible Sensor. AIDS Research and Human Retroviruses. 34(10). 835–837. 14 indexed citations
17.
Brooks, Kristina M., Jomy George, Alice K. Pau, et al.. (2018). Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine. Clinical Infectious Diseases. 67(2). 193–201. 45 indexed citations
18.
Malayeri, Ashkan A., Kristina M. Brooks, L. Henry Bryant, et al.. (2016). National Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain. Journal of the American College of Radiology. 13(3). 237–241. 85 indexed citations
19.
Giovinazzo, Hugh, Parag Kumar, Arif Sheikh, et al.. (2016). Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemotherapy and Pharmacology. 77(3). 565–573. 19 indexed citations
20.
Racz, Jennifer, Melissa Tai, Kristina M. Brooks, et al.. (2015). A Role for Low Density Lipoprotein Receptor-Related Protein 1 in the Cellular Uptake of Tissue Plasminogen Activator in the Lungs. Pharmaceutical Research. 33(1). 72–82. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jasper van der Lugt Breakdown of academic impact, for papers by Gavin Wong Breakdown of academic impact, for papers by Jinsil Kim Breakdown of academic impact, for papers by Jack Rodman Breakdown of academic impact, for papers by Stacey A. Rizza Breakdown of academic impact, for papers by Jennifer La Breakdown of academic impact, for papers by Qiwen Fang Breakdown of academic impact, for papers by Ranjababu Kulasegaram Breakdown of academic impact, for papers by Jori E. May Breakdown of academic impact, for papers by Heather Vezina
Rankless by CCL
2026